Firsocostat and cilofexor are orally administered inhibitors that are used to target ACC in clinical drug development for the treatment of steatohepatitis associated with metabolic dysfunction (144)
L., Yang, Y., Wong, H
Melanotan peptides offer a non-UV route to pigmentation, but their safety, dosage, and regulation remain under study
Beyond hormonal deficiency alone, the immunopathological characteristics of certain thyroid disorders may further exacerbate liver injury
Researchers observed that MC1R activation by MT-1 stimulates adenylyl cyclase, increasing intracellular cAMP, which activates CREB (cAMP response element binding protein) and induces MITF (microphthalmia-associated transcription factor) expression
Treatment recommendations, laboratory requirements, prescription eligibility, pricing, and medication availability are determined individually based on provider evaluation and clinical appropriateness